The company operates in the healthcare sector, which can be subject to regulatory changes and unpredictable market conditions. Insider selling activity has been observed, with company executives selling shares, which could be perceived as a lack of confidence in the company's future prospects. #...
Future of Medical Innovation: The Role of NLP in Healthcare The global COVID pandemic served as a wake-up call to healthcare providers […] Artificial IntelligenceIndustries August 16, 2024 How Do AI Applications in Banking Reshape the Industry?
Top-up Health Insurance- Buy Top-Up health insurance plans to boost your existing health insurance policy. Get Extra Cover in your health insurance with health top-up plan and Compare your plans from top health insurance companies in India.
Healthcare 5 hours ago Australia to invest $6.4m in First Nations-led cancer research The funding will support translational, community-based cancer projects in three key areas. Healthcare 5 hours ago Exclusives Diversity in Asia-Pacific region’s clinical trials ...
(注:募集金额参考https://www.beauhurst.com/blog/biotech-pharma-companies-uk/) 英国“生物&制药”30强公司/逐一分析 2.1 Artios Pharma 2.1.1 融资情况介绍 Artios Pharma总部位于剑桥Babraham研究所,成立于2015年,研究方向为靶向DNA损伤应答(DDR)途径的开创性癌症治疗方法,该公司于2021年入选Business Cloud...
Arnold, Matthew
For over 20 years, Belitsoft has been on the list of reputable, top custom healthcare software development companies, recognized by the Forbes Technology Council and featuring strong reviews on Gartner Insights. We create complex, modern custom healthcare solutions, which are cloud-based, analytics...
medical services. Undoubtedly, future trends in healthcare will center on advances in technology, Value-based care, personalization as well as retail healthcare. These changes and developments will open significant market opportunities for companies in the healthcare sector and other adjacent industries....
Artios Pharma在五轮融资中获得了2.45亿英镑的股权投资,投资者包括Arix Bioscience、CRT Pioneer Fund、Pfizer Venture Investments和SV Health Investors等。 2.1.2 主营业务详细介绍 Artios Pharma主营业务研究方向为DDR领域的药物发现,如合成致死。科学创始人Niall Martin博士和Graeme Smith博士是PARP抑制剂(现在由...
Microbiotica的投资者包括IP Group、Cambridge Innovation Capital、Flerie Invest和腾讯。 2.27.2 主营业务详细介绍 Microbiotica主营业务的推进,依托于基于微生物组的疗法、生物标志物和靶点的开发。公司通过威康桑格研究所(Wellcome Sanger Institute)十多年来开发的转化技术克服了人类肠道细菌相关的精确表征,同时正在将...